Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndrome

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

440 public trials 66 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Recruiting

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

NCT06616636

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT05010122

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

NCT07347418

Conditions: AML (Acute Myeloid Leukemia), Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

NCT04726241

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, +23 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

View all 184 locations

View Trial Details

Recruiting

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT04493164

Conditions: Acute Myeloid Leukemia With Gene Mutations, Bone Marrow Diseases, Hematologic Diseases, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

NCT07573111

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +14 more
Locations: Lucille Packard Children's Hospital of Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

NCT07582172

Conditions: Acute Myeloid Leukemia With Complex Karyotype, Bone Marrow Diseases, Hematologic Diseases, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

NCT07763054

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Agranulocytosis, +43 more
Locations: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine Hainan, China

View Trial Details

Recruiting

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

NCT04708054

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

NCT06287944

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details